• Phage attacks shown in new light

    From ScienceDaily@1:317/3 to All on Mon Mar 6 21:30:30 2023
    Phage attacks shown in new light

    Date:
    March 6, 2023
    Source:
    University of Pittsburgh
    Summary:
    New methodology and tools provide an opportunity to watch in
    unprecedented detail as a phage attacks a bacterium.


    Facebook Twitter Pinterest LinkedIN Email
    FULL STORY ==========================================================================
    As antibacterial resistance continues to render obsolete the use of some antibiotics, some have turned to bacteria-killing viruses to treat acute infections as well as some chronic illnesses.


    ========================================================================== Graham Hatfull, the Eberly Family Professor of Biotechnology in the
    Kenneth P.

    Dietrich School of Arts and Sciences at Pitt, has pioneered the use of
    these viruses -- bacteriophages, phages for short -- to treat infections
    in chronic diseases such as cystic fibrosis. Although the importance of resistance may have eluded the early discovers of antibiotics, Hatfull
    is intent on understanding how bacteria become resistant to phages.

    His lab has just discovered how a specific mutation in a bacterium results
    in phage resistance. The results were published Feb. 23, in the journal
    Nature Microbiology.

    The new methodology and tools his team developed also gave them the
    opportunity to watch in unprecedented detail as a phage attacks a
    bacterium. As the use of phage therapy expands, these tools can help
    others better understand how different mutations protect bacteria against invasion by their phages.

    For this study, the team started with Mycobacterium smegmatis, a harmless relative of the bacteria responsible for tuberculosis, leprosy and other
    hard- to-treat, chronic diseases. They then isolated a mutant form of the bacterium that is resistant to infection by a phage called Fionnbharth.

    To understand how the specific mutation in the lsr2 gene helps these
    resistant bacteria fight off a phage, the team first needed to understand
    how phages killed a bacteria without the relevant mutation.

    Carlos Guerrero-Bustamante, a fourth-year graduate student in Hatfull's
    lab, genetically engineered two special kinds of phages for this
    study. Some produced red fluorescence when they entered a bacterial
    cell. Others had segments of DNA that would stick to fluorescent molecules
    so phage DNA would light up in an infected cell.

    Following the fluorescent beacons, "We could see where the phage DNA
    entered the cell," Guerrero-Bustamante said. The imaging methods they used
    were designed by Charles Dulberger, a collaborator and co-first author
    of the paper who was then at Harvard T.H. Chan School of Public Health.

    "We saw for the first time how the phages take that first step of binding
    to cells and injecting their DNA into the bacteria," said Hatfull, who
    is also a Howard Hughes Medical Institute Professor. "Then we applied
    those insights to ask, 'So, how's it different if we get rid of the
    Lsr2 protein?'" The link between Lsr2 and phage resistance has not been previously known, but with their new methods and tools, the team clearly
    saw the critical role it played.

    Typically, Lsr2 helps bacteria replicate its own DNA. When a phage
    attacks, however, the virus co-opts the protein, using it to replicate
    phage DNA and overwhelm the bacteria. When the lsr2 gene is missing or defective -- as in the phage-resistant Mycobacterium smegmatis -- the
    bacteria doesn't make the protein and phages don't replicate enough to
    take over the bacterial cell.

    This was a surprise.

    "We didn't know Lsr2 had anything to do with bacteriophages," Hatfull
    said.

    These new tools can be used to uncover all manner of surprises written
    in the genes of phage-resistant bacteria. It may also help today's
    researchers and tomorrow's clinicians to better understand and take
    advantage of phages' abilities while avoiding the missteps that led to antibiotic resistance.

    "This paper focuses on just one bacterial protein," and its resistance
    to just one phage, Hatfull said, but its implications are wide. "There
    are lots of different phages and lots of other proteins."
    * RELATED_TOPICS
    o Plants_&_Animals
    # Bacteria # Microbes_and_More # Genetically_Modified
    # Microbiology # Biotechnology_and_Bioengineering #
    Biotechnology # Genetics # Biochemistry_Research
    * RELATED_TERMS
    o Dog_attack o Legionnaires'_disease o Visual_acuity o Tularemia
    o Tuberculosis o Piranha o Jane_Goodall o Bacteria

    ========================================================================== Story Source: Materials provided by University_of_Pittsburgh. Original
    written by Brandie Jefferson. Note: Content may be edited for style
    and length.


    ========================================================================== Journal Reference:
    1. Charles L. Dulberger, Carlos A. Guerrero-Bustamante, Sia^n V. Owen,
    Sean
    Wilson, Michael G. Wuo, Rebecca A. Garlena, Lexi A. Serpa, Daniel A.

    Russell, Junhao Zhu, Ben J. Braunecker, Georgia R. Squyres,
    Michael Baym, Laura L. Kiessling, Ethan C. Garner, Eric J. Rubin,
    Graham F. Hatfull.

    Mycobacterial nucleoid-associated protein Lsr2 is required for
    productive mycobacteriophage infection. Nature Microbiology, 2023;
    DOI: 10.1038/ s41564-023-01333-x ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2023/03/230306143446.htm

    --- up 1 year, 1 week, 10 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)